HIGH THERAPEUTIC EFFICIENCY WITH LEDIPASVIR/SOFOSBUVIR FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C IN PORTUGAL

被引：0
|
作者：
Ferreira, D. [1 ]
Felix, J. [1 ]
Almeida, J. [1 ]
Mota, M. [1 ]
Afonso Silva, M. [1 ]
Silva, P. [1 ]
Vandewalle, B. [1 ]
Velosa, J. [2 ]
Marinho, R. [2 ]
Aldir, I [3 ]
Carvalho, A. [4 ]
Valente, C. [5 ]
Macedog, G. [6 ]
Sarmento e Castro, R. [7 ]
Pedroto, I [8 ]
机构：
[1] Exigo Consultores, Alhos Vedros, Portugal
[2] Ctr Hosp Lisboa Norte, Hosp Santa Maria, EPE, Lisbon, Portugal
[3] Ctr Hosp Lisboa Ocident, Hosp Egas Moniz, Lisbon, Portugal
[4] Ctr Hosp & Univ Coimbra, Coimbra, Portugal
[5] Ctr Hosp & Univ Coimbra, EPE, Coimbra, Portugal
[6] Hosp Sao Joao, Oporto, Portugal
[7] Ctr Hosp Porto, EPE, Oporto, Portugal
[8] Ctr Hosp Porto, Oporto, Portugal
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1924
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN14
引用
收藏
页码：A578 / A578
页数：1
相关论文
共 50 条
  • [1] HIGH THERAPEUTIC EFFICIENCY WITH SOFOSBUVIR FOR THE TREATMENT OF CHRONIC HEPATITIS C
    Felix, J.
    Silva, M.
    Ferreira, D.
    Vandewalle, B.
    Guerra, I
    Cure, S.
    Aldir, I
    Carvalho, A.
    Macedo, G.
    Marinho, R. T.
    Pedroto, I
    Ramalho, F.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A371 - A371
  • [2] Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients
    Abdelaty, Lamiaa N.
    Elnaggar, Ahmed A.
    Said, Amira A.
    Hussein, Raghda R. S.
    [J]. CURRENT DRUG SAFETY, 2020, 15 (01) : 53 - 60
  • [3] Treatment of Chronic Hepatitis C Genotype 3 With Ledipasvir and Sofosbuvir: An Observational Study
    Dar, Gulzar A.
    Yattoo, Ghulam N.
    Gulzar, Ghulam M.
    Sodhi, Jaswinder S.
    Gorka, Suresh
    Laway, Mushtaq A.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (02) : 227 - 231
  • [4] Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1
    Kumari, Radhika
    Nguyen, Mindie H.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (05) : 739 - 748
  • [5] Ledipasvir/Sofosbuvir in the Treatment of Hepatitis C Virus Genotype 6
    Nguyen, Andrew A.
    Weisberg, Ilan
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S368 - S368
  • [6] COST-EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR FOR THE TREATMENT OF GENOTYPE 1 OR 4 CHRONIC HEPATITIS C IN SCOTLAND
    Dillon, J.
    Treharne, C.
    Howells, R.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 : S635 - S635
  • [7] Cost-utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan
    Igarashi, Ataru
    Tang, Wentao
    Guerra, Ines
    Marie, Lucile
    Cure, Sandrine
    Lopresti, Michael
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (01) : 11 - 21
  • [8] COST-EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR FOR THE TREATMENT OF GENOTYPE 1 OR 4 CHRONIC HEPATITIS C IN ENGLAND AND WALES
    Howells, R.
    Trehame, C.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A589 - A589
  • [9] Ledipasvir/sofosbuvir with or without ribavirin for the treatment of chronic hepatitis C genotype 1: A pairwise meta-analysis
    Ferreira, Vinicius L.
    Assis Jarek, Nayara A.
    Tonin, Fernanda S.
    Borba, Helena H. L.
    Wiens, Astrid
    Muzzillo, Dominique A.
    Pontarolo, Roberto
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 (04) : 749 - 755
  • [10] Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia
    Younossi, Z. M.
    Chan, H. L. Y.
    Dan, Y. Y.
    Lee, M. H.
    Lim, Y. -S.
    Kruger, E.
    Tan, S. C.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2018, 25 (03) : 228 - 235
12345